{
    "clinical_study": {
        "@rank": "153131", 
        "arm_group": [
            {
                "arm_group_label": "hyaluronic acid", 
                "arm_group_type": "Experimental", 
                "description": "intravesical instillation of 40 mg of hyaluronic acid at 6 specific time points: 1,2,3 and 4 weeks postoperatively 2 and 3 months postoperatively"
            }, 
            {
                "arm_group_label": "retrospective control patients", 
                "arm_group_type": "No Intervention", 
                "description": "retrospective control patients"
            }
        ], 
        "brief_summary": {
            "textblock": "Prospective trial which includes instillation of intravesical hyaluronic acid in an attempt\n      to reduce the incidence of urinary tract infections in patients after orthotopic neobladder\n      reconstruction."
        }, 
        "brief_title": "Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection", 
        "condition": "Urinary Tract Infection", 
        "condition_browse": {
            "mesh_term": "Urinary Tract Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing radical cystectomy and orthotopic neobladder reconstruction\n\n        Exclusion Criteria:\n\n          -  patients <18 years and unwilling to participate in this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02034890", 
            "org_study_id": "RMC-7350"
        }, 
        "intervention": {
            "arm_group_label": "hyaluronic acid", 
            "description": "intravesical instillation of 40 mg of hyaluronic acid in 6 specific time points: 1,2,3 and 4 weeks postoperatively (After radical cystectomy and orthotopic neobladder reconstruction) 2 and 3 months postoperatively", 
            "intervention_name": "Hyaluronic Acid", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Hyaluronic Acid"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "orthotopic neobladder", 
            "urinary tract infection", 
            "intravesical instillation", 
            "hyaluronic acid"
        ], 
        "lastchanged_date": "January 10, 2014", 
        "location": {
            "contact": {
                "last_name": "Hanan Goldberg", 
                "phone": "972544315412"
            }, 
            "facility": {
                "address": {
                    "city": "Petach Tiqva", 
                    "country": "Israel", 
                    "zip": "49100"
                }, 
                "name": "Urology department, Rabin Medical Center"
            }, 
            "investigator": {
                "last_name": "Hanan Goldberg, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Is Intra - Neobladder Installations of Hyaluronic Acid, Effective in Reducing Neobladder Orthotropic Reconstruction Post-operative Urinary Tract Infections?", 
        "overall_contact": {
            "email": "gohanan@gmail.com", 
            "last_name": "Hanan Goldberg", 
            "phone": "972544315412"
        }, 
        "overall_official": {
            "affiliation": "Rabin Medical Center", 
            "last_name": "Hanan Goldberg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "positive urinary culture", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02034890"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rabin Medical Center", 
            "investigator_full_name": "Hanan Goldberg", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "urinary tract infection", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Rabin Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rabin Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}